This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources Oct. 12, 2010
 
ASCLS eNewsBytes
Oct. 12, 2010
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources
 
 
The transformation of medicine:
Labs key to new paradigm

Clinical Laboratory News    Share   Share on FacebookTwitterShare on LinkedinE-mail article
Tackling an emotionally, financially, and physically draining disease poised to exact a huge toll on society in the coming decade. Harnessing the power of the most sophisticated biological, analytical, and mathematical constructs to understand wellness and disease parameters for individual patients. Using cutting-edge molecular science to reprogram cells and bring personalized and regenerative medicine closer to reality. More



Early lung cancer detection: Optical technology shows potential for prescreening patients at high risk
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers from Northwestern University and NorthShore University HealthSystem have developed a method to detect early signs of lung cancer by examining cheek cells in humans using pioneering biophotonics technology. The optical technique is called partial wave spectroscopic microscopy, which can detect cell features as small as 20 nanometers, uncovering differences in cells that appear normal. More

Trastuzumab-DM1 is efficacious and has a good safety profile in patients with metastatic breast cancer
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Positive results of the first-ever phase 2 study of an anti-HER2 antibody-drug conjugate, trastuzumab-DM1 (T-DM1), as first-line therapy in patients with metastatic breast cancer confirm good efficacy and lower toxicity than standard therapy. Following on from 2 previous single-group phase 2 studies in extensively pretreated patients with HER2-positive metastatic breast cancer, these results are from the first randomized phase 2 study comparing the efficacy and safety of T-DM1 vs trastuzumab plus docetaxel. More

Bacteria strut their stuff
Science News via U.S.News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Some bacteria can just stand up and toddle away on hairlike legs, a new study shows. The finding could help scientists better understand how bacteria form dense antibiotic-resistant communities called biofilms and may lead to better ways to combat troublesome and sometimes deadly microbes. Researchers had already documented bacteria swimming through liquids or crawling on their bellies across a surface, but no one had ever seen bacteria getting up and walking. More



Honeybees killed by virus, fungus combo
CBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The mass deaths of honey-bee colonies in the U.S. may be caused by a lethal combination of fungi and viruses, suggests new research. Researchers, predominantly from the University of Montana, have identified three viruses — Varroa destructor-1, Kakugo and an invertebrate iridescent virus — in dead honeybees felled by what is known as colony collapse disorder. They also found these bees were infected with two fungi — Nosema apis and Nosema ceranae. More

Menstrual blood stem cells could repair stroke damage to the brain
AOL News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stem cells derived from menstrual blood are hitting the laboratory, with researchers speculating that a woman's period might be a boon for recovering stroke patients. A collaboration between researchers at the University of South Florida, along with a stem cell company and a biotech firm, will investigate the efficacy of transplanted menstrual-blood-derived stem cells in repairing brain damage incurred by a stroke. More

Bio-Rad's MRSASelect™ - Results on Your Time

Chromogenic Medium for Screening MRSA
With high sensitivity and specificity, this test can identify MRSA carriers in just 18–28 hours. The test procedure is simple, and results are easy to read and interpret. 
MORE


Biomarker may determine disease activity, predict next relapse in MS
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Myxovirus resistance protein A (MxA) messenger RNA (mRNA) level in peripheral blood correlates with clinical and radiologic measures of disease activity in patients with newly diagnosed multiple sclerosis, a new study shows. "MxA mRNA has potential as a biomarker for clinical disease activity in MS," Laura F. van der Voort, MD, and colleagues from VU Medical Center, Amsterdam, the Netherlands, conclude in an article in Neurology. More

Most Americans back embryonic stem cell research
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Americans overwhelmingly support embryonic stem cell research, and that backing stretches across a broad range of demographic groups, including Republicans, Catholics and born-again Christians, according to a new Harris Interactive/HealthDay poll. Almost three-quarters (72 percent) of the adults surveyed believe that scientists should be allowed to use embryonic stem cells left over from in vitro fertilization procedures to search for potential treatments or ways to prevent diseases such as Parkinson's disease, Alzheimer's, diabetes and other conditions. More
 
 
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Oct. 5, 2010
  • Sep. 28, 2010
  • Dedicated - Nuaire Sept 2010
  • Sept. 21, 2010
  • Sep. 14, 2010
  •  RSS Feed
    Most popular articles